Ciclib 100mg Capsule

About Ciclib 100mg Capsule

Ciclib 100mg Capsule contains Palbociclib, a targeted anticancer medication belonging to the cyclin-dependent kinase (CDK) 4/6 inhibitor class. It is primarily used in combination with hormone therapy for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer in adults. Palbociclib works by blocking specific enzymes responsible for cancer cell growth and division, helping to slow disease progression and improve treatment outcomes. The dosage of Ciclib 100mg Capsule is determined by the treating oncologist based on the patient's medical condition, overall health, and response to therapy, and it should be taken exactly as prescribed. This medication is commonly used alongside other hormonal treatments to enhance its effectiveness in controlling cancer growth. Before starting treatment, patients should inform their healthcare provider about any existing medical conditions, infections, liver problems, or other medications they are taking, as regular monitoring of blood counts and overall health may be required during therapy. Common side effects may include fatigue, infections, nausea, hair thinning, mouth sores, and decreased blood cell counts, which can increase the risk of infections. Regular follow-up appointments and laboratory tests are essential to ensure the safe and effective use of Ciclib 100mg Capsule. By targeting the pathways that drive cancer cell multiplication, Ciclib 100mg plays an important role in the modern management of advanced breast cancer and helps improve long-term disease control.